Amphastar Pharmaceuticals Share Holder Equity 2012-2024 | AMPH
Amphastar Pharmaceuticals share holder equity from 2012 to 2024. Share holder equity can be defined as the sum of preferred and common equity items
Amphastar Pharmaceuticals Annual Share Holder Equity
(Millions of US $) |
| 2023 |
$639 |
| 2022 |
$529 |
| 2021 |
$446 |
| 2020 |
$449 |
| 2019 |
$428 |
| 2018 |
$364 |
| 2017 |
$334 |
| 2016 |
$329 |
| 2015 |
$296 |
| 2014 |
$282 |
| 2013 |
$252 |
| 2012 |
$233 |
| 2011 |
$0 |
| 2009 |
$159 |
Amphastar Pharmaceuticals Quarterly Share Holder Equity
(Millions of US $) |
| 2024-06-30 |
$713 |
| 2024-03-31 |
$672 |
| 2023-12-31 |
$639 |
| 2023-09-30 |
$595 |
| 2023-06-30 |
$589 |
| 2023-03-31 |
$549 |
| 2022-12-31 |
$529 |
| 2022-09-30 |
$505 |
| 2022-06-30 |
$499 |
| 2022-03-31 |
$480 |
| 2021-12-31 |
$446 |
| 2021-09-30 |
$430 |
| 2021-06-30 |
$467 |
| 2021-03-31 |
$451 |
| 2020-12-31 |
$449 |
| 2020-09-30 |
$451 |
| 2020-06-30 |
$442 |
| 2020-03-31 |
$423 |
| 2019-12-31 |
$428 |
| 2019-09-30 |
$434 |
| 2019-06-30 |
$432 |
| 2019-03-31 |
$380 |
| 2018-12-31 |
$364 |
| 2018-09-30 |
$341 |
| 2018-06-30 |
$321 |
| 2018-03-31 |
$327 |
| 2017-12-31 |
$334 |
| 2017-09-30 |
$331 |
| 2017-06-30 |
$333 |
| 2017-03-31 |
$326 |
| 2016-12-31 |
$329 |
| 2016-09-30 |
$328 |
| 2016-06-30 |
$307 |
| 2016-03-31 |
$297 |
| 2015-12-31 |
$296 |
| 2015-09-30 |
$284 |
| 2015-06-30 |
$285 |
| 2015-03-31 |
$279 |
| 2014-12-31 |
$282 |
| 2014-09-30 |
$283 |
| 2014-06-30 |
$288 |
| 2014-03-31 |
$252 |
| 2013-12-31 |
$252 |
| 2013-09-30 |
$0 |
| 2013-06-30 |
$0 |
| 2013-03-31 |
$0 |
| 2012-12-31 |
$233 |
| 2012-09-30 |
|
| 2012-06-30 |
|
| 2012-03-31 |
|
| 2011-12-31 |
$0 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$2.469B |
$0.644B |
|
Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and prefilled disposable emergency syringes for crash cart use. Amphastar Pharmaceuticals, Inc. is headquartered in Rancho Cucamonga, California.
|
